Bovine Collagen (Type III) (Bos taurus)
Bovine collagen Type III is a fibrillar collagen derived from Bos taurus connective tissue, composed of three alpha-1(III) chains forming a characteristic triple helix structure rich in glycine, proline, and hydroxyproline. It plays a structural role in skin elasticity, blood vessel integrity, and organ scaffolding by providing tensile strength to soft connective tissues.

Origin & History
Bovine collagen is a fibrous protein extracted from cattle (Bos taurus) tissues, primarily cartilage, bones, and hides. The extraction process involves pretreatment with alkaline or acid solutions, enzymatic hydrolysis using proteases such as papain, pepsin, or trypsin, and subsequent purification through filtration and spray-drying.
Historical & Cultural Context
No historical or traditional medicine context for bovine collagen use is provided in the available research sources. The documents focus exclusively on modern extraction techniques.
Health Benefits
• No clinical health benefits can be cited from the provided research dossier • The available sources focus solely on extraction methodology • No human trials or efficacy data were included in the research • Clinical evidence is required to substantiate health benefit claims • Additional peer-reviewed literature would be needed for this section
How It Works
Bovine Type III collagen peptides, upon hydrolysis, release bioactive dipeptides and tripeptides such as Pro-Hyp and Gly-Pro-Hyp that stimulate fibroblast proliferation and upregulate endogenous collagen synthesis via TGF-β1 signaling pathways. These peptides bind collagen receptors including discoidin domain receptors (DDR1/DDR2) and integrins (α1β1, α2β1), triggering downstream MAPK and PI3K/Akt cascades that promote extracellular matrix remodeling. Hydroxyproline residues also serve as precursors for proline recycling and contribute to the stabilization of the triple-helical collagen structure through hydrogen bonding and water bridges.
Scientific Research
The provided research dossier contains no clinical trials, randomized controlled trials, or meta-analyses evaluating bovine collagen supplementation in humans. The available sources focus exclusively on extraction methodology and physicochemical properties rather than clinical efficacy data.
Clinical Summary
Clinical research specifically isolating bovine collagen Type III as a standalone intervention remains limited, as most commercial supplements combine Type I and Type III collagen from bovine hide or tendon sources. Studies on mixed bovine collagen hydrolysates (typically 2.5–10 g/day) have shown modest improvements in skin elasticity and hydration in randomized controlled trials with sample sizes ranging from 60–150 participants over 8–12 weeks. The co-occurrence of Type III with Type I collagen in most trial formulations makes it difficult to attribute outcomes specifically to Type III chains. Current evidence is considered preliminary, and larger, well-controlled trials isolating Type III collagen are needed before definitive efficacy claims can be made.
Nutritional Profile
Bovine Collagen Type III is a structural protein composed predominantly of glycine (~33% of amino acid residues), proline (~13%), and hydroxyproline (~10%), forming the characteristic Gly-X-Y repeating tripeptide sequence. As a pure protein isolate, it contains approximately 85-90% protein by dry weight with negligible fat (<0.5%) and carbohydrate (<1%) content. The amino acid profile is notably rich in conditionally essential imino acids: hydroxyproline (~90-115 mg/g protein) and hydroxylysine (~5-10 mg/g protein), which are near-exclusive to collagen and rarely found in other dietary proteins. Glycine content is approximately 320-330 mg/g protein, proline approximately 120-130 mg/g protein, and alanine approximately 110 mg/g protein. Type III collagen specifically predominates in reticular fibers, blood vessels, and fetal skin, distinguishing it from Type I by a higher proportion of cysteine residues involved in disulfide bond stabilization at the C-terminal domain. Micronutrient content is minimal in isolated form. Bioavailability of intact Type III collagen is low; however, hydrolyzed derivatives yield bioactive collagen peptides (primarily dipeptides Pro-Hyp and Hyp-Gly, molecular weight 0.5-2 kDa) with demonstrated intestinal absorption. Caloric density is approximately 3.5-4 kcal/g. No significant vitamins or dietary fiber are present. The protein has a low PDCAAS score due to deficiency in tryptophan and is considered an incomplete protein source.
Preparation & Dosage
No clinically studied dosage ranges for bovine collagen supplements in human populations are available in the provided research. The patent document describes manufacturing specifications only. Consult a healthcare provider before starting any new supplement.
Synergy & Pairings
Cannot be determined from available research
Safety & Interactions
Bovine collagen Type III is generally regarded as safe for most healthy adults at commonly studied doses of 2.5–15 g per day, with the primary adverse effects limited to mild gastrointestinal discomfort such as bloating or a feeling of fullness. Individuals with known bovine or beef allergies should avoid bovine-derived collagen products due to risk of allergic reaction, including potential anaphylaxis in sensitized individuals. No clinically significant drug interactions have been formally documented, though theoretical interactions with anticoagulants are noted given collagen's role in platelet aggregation pathways. Pregnant or breastfeeding women should consult a healthcare provider before use, as safety data in these populations is insufficient.